Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomised Double Blind, Placebo Controlled Study of Efficacy, Safety and Tolerability of Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp.

NCT01137630 is registered in ClinicalTrials.gov with Moberg Pharma AB as lead sponsor.

NCT NCT01137630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01137630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomised Double Blind, Placebo Controlled Study of Efficacy, Safety and Tolerability of Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp.
Lead sponsor
Moberg Pharma AB
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2007
Completion date
May 31, 2007
Enrollment
98 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

seborrhoeic dermatitis of the scalp